Abbott Laboratories announced that it will lay off 700 employees as part of ongoing restructuring efforts. Most of the layoffs will affect employees who manufacture the company's heart stents and diagnostic tests. About 300 of the eliminated positions are at the company's stent business in Southern California. Less than 200 others involve the company's diagnostic business in Lake County, Illinois. Other layoffs affect the company's pharmaceutical manufacturing operation in Puerto Rico, among other places.